Ascendis Pharma A/S
ASNDNASDAQ
USReal-Time Price
USReal-Time Price$234.33USD
+4.38 (+1.90%)Today
$232.00-2.33 (-0.99%)After Hours5:16 PM ET
BTI Score
Near Future
59
Long Term
69
BTI Fair Market Cap
$15.73B
-10.68% vs fair
Hold
Ascendis Pharma A/S (ASND) Earnings
Ascendis Pharma A/S (ASND) earnings: next report date, EPS and revenue consensus, historical surprises and the full quarterly results timeline.
Earnings Trends
Earnings Per Share
Revenue Beat Rate
70%
Beat
7Meet
0Miss
3Total
10EPS Beat Rate
0%
Beat
0Meet
0Miss
0Total
0Earnings Consistency
0%
Both Beat
0Other
0Total
0Quarterly EPS Performance
Recent results and upcoming quarter
Q2 FY26
30 / 06 / 2026
Estimate—
Actual—
Surprise—
Q1 FY26
31 / 03 / 2026
Estimate—
Actual—
Surprise—
Q4 FY25
31 / 12 / 2025
Estimate—
Actual—
Surprise—
Q4 FY26
11 / 11 / 2026
Estimate$0.91
Actual—
Surprise—
Revenue vs Earnings Over Time
Revenue (B USD)
Net Income (B USD)
Profit Margin (%)
EPS: Estimate vs Reported
Earnings History
| Quarter | EPS Est. | Reported EPS | Surprise | Rev. Est. | Reported Rev. | Date |
|---|---|---|---|---|---|---|
| Q2 FY26 | — | — | —▼ Miss | $376.75M | $387.22M | 30 / 06 / 2026 |
| Q1 FY26 | — | — | —▼ Miss | $362.47M | $285.45M | 31 / 03 / 2026 |
| Q4 FY25 | — | — | —▼ Miss | $285.35M | $290.38M | 31 / 12 / 2025 |
| Q3 FY25 | — | — | —▼ Miss | $246.91M | $250.71M | 30 / 09 / 2025 |
| Q2 FY25 | — | — | —▼ Miss | $163.17M | $216.28M | 30 / 06 / 2025 |
| Q1 FY25 | — | — | —▼ Miss | $98.56M | $123.97M | 31 / 03 / 2025 |
| Q2 FY24 | — | — | —▼ Miss | $94.74M | $38.75M | 30 / 06 / 2024 |
| Q1 FY24 | — | — | —▼ Miss | $85.72M | $103.11M | 31 / 03 / 2024 |
| Q4 FY23 | — | — | —▼ Miss | $97.02M | $148.62M | 31 / 12 / 2023 |
| Q3 FY23 | — | — | —▼ Miss | $52.54M | $52.02M | 30 / 09 / 2023 |
Source: FMP Earnings Calendar API. Surprise = (Actual − Estimate) / |Estimate| × 100.
ASND upcoming earnings call
11 / 11 / 2026
ScheduledEPS Est: $0.91